RJ Hift, S Thunell… - Pharmacology & Therapeutics, 2011 - Elsevier ... Drugs in porphyria: from observation to a modern algorithm-based system for the prediction of porphyrogenicity. ... b Porphyria Centre Sweden, Department of Laboratory Medicine, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden. ... All 2 versions
[HTML] from nih.govJK Wickliffe, SZ Abdel-Rahman, C Lee… - Molecular …, 2011 - ncbi.nlm.nih.gov ... PMCID: PMC3060985. Copyright 2011, The Feinstein Institute for Medical Research. CYP1A2*1F and GSTM1 Alleles Are Associated with Susceptibility to Porphyria Cutanea Tarda. ... Associations Among Behavior-Related Susceptibility Factors in Porphyria Cutanea Tarda. Clin. ... Related articles - All 4 versions
DF Bishop, S Clavero, N Mohandas… - Molecular medicine ( …, 2011 - ncbi.nlm.nih.gov ... [Epub ahead of print] Congenital Erythropoietic Porphyria: Characterization of Murine Models of the Severe Common (C73R/C73R) and Later-Onset Genotypes. ... Of note, even the mildest genotype, V99L/V99L, exhibited porphyria in utero that disappeared by two months of age. ...
X Qin, Y Tan, L Wang, Z Wang, B Wang, X Wen… - The FASEB Journal, 2011 - FASEB ... Variegate porphyria (VP) is a type of acute hepatic porphyria, an autosomal dominant human disease (1,–,3). Symptoms include acute abdominal pain, neurological ... for 2 h. The Ni 2+ -NTA column was then washed with 4 column volumes of wash buffer [50 mM NaH 2 PO 4 (pH ... Related articles - All 3 versions
JK Dowman, BK Gunson, DF Mirza… - Liver …, 2011 - Wiley Online Library Page 1. 1 LT-11-056 Liver transplantation for acute intermittent porphyria is complicated by a high rate of hepatic artery thrombosis ... Abbreviations AIP acute intermittent porphyria ALA 5-aminolaevulinic acid HAT hepatic artery thrombosis LT liver transplantation ... Related articles - All 2 versions